Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Feb-24 12:50 PM View:  | Bisker-Leib Vered Chief Executive Officer Director | Compass Therapeutics, Inc. (CMPX) | 08-Feb-24 | Payment of Exercise | 49,198 | $1.45 | $71,337.10 | (2%) 3.17M to 3.12M | |
| 09-Feb-24 12:49 PM View: | Schuetz Thomas J. PRESIDENT Director | Compass Therapeutics, Inc. (CMPX) | 08-Feb-24 | Payment of Exercise | 44,782 | $1.45 | $64,933.90 | (< 1%) 6.62M to 6.57M | |
| 10-Jan-24 10:31 AM View: | Schuetz Thomas J. President of R&D Director | Compass Therapeutics, Inc. (CMPX) | 09-Jan-24 | Grant | 637,500 | $1.93 | $1,230,380.00 | 11% 5.98M to 6.62M | |
| 10-Jan-24 10:31 AM View: | Bisker-Leib Vered Chief Executive Officer Director | Compass Therapeutics, Inc. (CMPX) | 09-Jan-24 | Grant | 1,753,120 | $1.93 | $3,383,530.00 | 123% 1.42M to 3.17M | |
| 21-Nov-23 2:08 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 17-Nov-23 | Payment of Exercise | 44,025 | $1.50 | $66,037.50 | (< 1%) 6.02M to 5.98M | |
| 21-Nov-23 2:10 PM View: | Bisker-Leib Vered Chief Operating Officer | Compass Therapeutics, Inc. (CMPX) | 17-Nov-23 | Payment of Exercise | 64,415 | $1.50 | $96,622.50 | (4%) 1.48M to 1.42M | |
| 10-Mar-23 1:34 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 10-Mar-23 | Market Purchase | 10,000 | $3.37 | $33,700.00 | < 1% 6.01M to 6.02M | (6%) |
| 27-Feb-23 11:39 AM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 27-Feb-23 | Purchase | 20,000 | $3.98 | $79,600.00 | < 1% 5.99M to 6.01M | |
| 15-Feb-23 10:47 AM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 15-Feb-23 | Market Purchase | 20,000 | $3.86 | $77,200.00 | < 1% 5.97M to 5.99M | (18%) |
| 09-Feb-23 3:03 PM View: | Bisker-Leib Vered Chief Operating Officer | Compass Therapeutics, Inc. (CMPX) | 08-Feb-23 | Grant | 400,000 | -- | -- | 37% 1.08M to 1.48M | |
| 09-Feb-23 4:23 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 08-Feb-23 | Grant | 500,000 | -- | -- | 9% 5.47M to 5.97M | |
| 31-Jan-23 10:14 AM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 31-Jan-23 | Purchase | 20,000 | $4.05 | $81,000.00 | < 1% 5.45M to 5.47M | |
| 24-Jan-23 10:49 AM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 24-Jan-23 | Purchase | 20,000 | $4.19 | $83,800.00 | < 1% 5.43M to 5.45M | |
| 25-Nov-22 4:41 PM View: | Bisker-Leib Vered Chief Operating Officer | Compass Therapeutics, Inc. (CMPX) | 25-Nov-22 | Sale | 2 | $4.36 | $8.72 | (< 1%) 1.06M to 1.06M | |
| 25-Nov-22 4:41 PM View: | Bisker-Leib Vered Chief Operating Officer | Compass Therapeutics, Inc. (CMPX) | 23-Nov-22 | Sale | 9,569 | $4.30 | $41,146.70 | (< 1%) 1.07M to 1.06M | |
| 25-Nov-22 4:41 PM View: | Bisker-Leib Vered Chief Operating Officer | Compass Therapeutics, Inc. (CMPX) | 22-Nov-22 | Private Sale | 14,929 | $4.19 | $62,552.50 | (1%) 1.08M to 1.07M | |
| 22-Nov-22 4:15 PM View: | Bisker-Leib Vered Chief Operating Officer | Compass Therapeutics, Inc. (CMPX) | 21-Nov-22 | Sale | 16,035 | $4.34 | $69,591.90 | (1%) 1.1M to 1.08M | |
| 22-Nov-22 4:15 PM View: | Bisker-Leib Vered Chief Operating Officer | Compass Therapeutics, Inc. (CMPX) | 18-Nov-22 | Private Sale | 6,226 | $4.40 | $27,394.40 | (< 1%) 1.11M to 1.11M | |
| 10-Nov-22 4:44 PM View: | Orbimed Advisors LLC Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 08-Nov-22 | Market Purchase Duplicate | 402,000 | $3.21 | $1,290,420.00 | 2% 18.39M to 18.79M | (1%) |
| 10-Nov-22 4:38 PM View: | Gordon Carl L Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 08-Nov-22 | Market Purchase | 402,000 | $3.21 | $1,290,420.00 | 2% 18.39M to 18.79M | (1%) |
| 28-Sep-22 4:45 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 28-Sep-22 | Private Purchase | 10,000 | $2.32 | $23,200.00 | < 1% 5.42M to 5.43M | |
| 27-Sep-22 9:47 AM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 26-Sep-22 | Private Purchase | 15,000 | $2.27 | $34,050.00 | < 1% 5.41M to 5.42M | |
| 08-Sep-22 10:12 AM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 07-Sep-22 | Market Purchase | 15,000 | $3.03 | $45,450.00 | < 1% 5.39M to 5.41M | 5% |
| 01-Sep-22 2:37 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 01-Sep-22 | Market Purchase | 15,000 | $2.83 | $42,450.00 | < 1% 5.38M to 5.39M | 12% |
| 17-Aug-22 4:06 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 17-Aug-22 | Market Purchase | 15,000 | $3.05 | $45,750.00 | < 1% 5.36M to 5.38M | 4% |
| 10-Aug-22 10:51 AM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 10-Aug-22 | Market Purchase | 15,000 | $2.64 | $39,600.00 | < 1% 5.35M to 5.36M | 20% |
| 02-Aug-22 9:15 AM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 01-Aug-22 | Market Purchase | 15,000 | $2.58 | $38,700.00 | < 1% 5.33M to 5.35M | 23% |
| 21-Jun-22 1:41 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 21-Jun-22 | Market Purchase | 20,000 | $2.80 | $56,000.00 | < 1% 5.31M to 5.33M | 13% |
| 17-Jun-22 4:46 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 16-Jun-22 | Private Purchase | 20,000 | $2.34 | $46,800.00 | < 1% 5.29M to 5.31M | |
| 13-Jun-22 3:59 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 13-Jun-22 | Private Purchase | 30,000 | $2.29 | $68,700.00 | < 1% 5.26M to 5.29M | |
| 07-Jun-22 11:50 AM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 06-Jun-22 | Market Purchase | 30,000 | $2.83 | $84,900.00 | < 1% 5.23M to 5.26M | 12% |
| 01-Jun-22 12:33 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 01-Jun-22 | Market Purchase | 20,000 | $3.03 | $60,600.00 | < 1% 5.21M to 5.23M | 5% |
| 26-May-22 2:58 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 26-May-22 | Market Purchase | 20,000 | $3.04 | $60,800.00 | < 1% 5.19M to 5.21M | 4% |
| 24-May-22 8:09 AM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 23-May-22 | Market Purchase | 18,355 | $2.72 | $49,925.60 | < 1% 5.17M to 5.19M | 17% |
| 17-May-22 3:17 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 17-May-22 | Private Purchase | 20,215 | $2.47 | $49,931.10 | < 1% 5.15M to 5.17M | |
| 13-May-22 5:45 PM View: | Orbimed Advisors LLC Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 13-May-22 | Purchase | 30,722 | $2.49 | $76,497.80 | < 1% 18.36M to 18.39M | |
| 13-May-22 5:48 PM View: | Gordon Carl L Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 13-May-22 | Purchase Duplicate | 30,722 | $2.49 | $76,497.80 | < 1% 18.36M to 18.39M | |
| 13-May-22 5:45 PM View: | Orbimed Advisors LLC Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 12-May-22 | Purchase | 97,094 | $2.35 | $228,171.00 | < 1% 18.26M to 18.36M | |
| 13-May-22 5:48 PM View: | Gordon Carl L Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 12-May-22 | Purchase Duplicate | 97,094 | $2.35 | $228,171.00 | < 1% 18.26M to 18.36M | |
| 13-May-22 5:45 PM View: | Orbimed Advisors LLC Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 11-May-22 | Private Purchase | 64,700 | $1.79 | $115,813.00 | < 1% 18.2M to 18.26M | |
| 13-May-22 5:48 PM View: | Gordon Carl L Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 11-May-22 | Private Purchase Duplicate | 64,700 | $1.79 | $115,813.00 | < 1% 18.2M to 18.26M | |
| 10-May-22 6:21 PM View: | Orbimed Advisors LLC Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 10-May-22 | Purchase Duplicate | 24,447 | $1.60 | $39,115.20 | < 1% 18.17M to 18.2M | |
| 10-May-22 6:19 PM View: | Gordon Carl L Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 10-May-22 | Purchase | 24,447 | $1.60 | $39,115.20 | < 1% 18.17M to 18.2M | |
| 10-May-22 2:15 PM View: | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Director | Compass Therapeutics, Inc. (CMPX) | 10-May-22 | Private Purchase | 27,836 | $1.80 | $50,104.80 | < 1% 5.13M to 5.15M | |
| 10-May-22 6:21 PM View: | Orbimed Advisors LLC Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 09-May-22 | Purchase Duplicate | 90,712 | $1.56 | $141,511.00 | < 1% 18.08M to 18.17M | |
| 10-May-22 6:19 PM View: | Gordon Carl L Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 09-May-22 | Purchase | 90,712 | $1.56 | $141,511.00 | < 1% 18.08M to 18.17M | |
| 10-May-22 6:21 PM View: | Orbimed Advisors LLC Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 06-May-22 | Private Purchase Duplicate | 10,200 | $1.63 | $16,626.00 | < 1% 18.07M to 18.08M | |
| 10-May-22 6:19 PM View: | Gordon Carl L Director 10% Owner | Compass Therapeutics, Inc. (CMPX) | 06-May-22 | Private Purchase | 10,200 | $1.63 | $16,626.00 | < 1% 18.07M to 18.08M | |
| 18-Nov-21 7:00 PM View: | Schuetz Thomas J. Chief Executive Officer Director | Compass Therapeutics, Inc. (CMPX) | 16-Nov-21 | Grant | 600,000 | -- | -- | 13% 4.53M to 5.13M | |
| 18-Nov-21 7:00 PM View: | Bisker-Leib Vered Chief Operating Officer | Compass Therapeutics, Inc. (CMPX) | 16-Nov-21 | Grant | 600,000 | -- | -- | 117% 513.4K to 1.11M |
